Shire plc Notice of Results

 
TIDMSHP 
 
Shire to announce third quarter 2016 results 
 
Dublin, Ireland - October 19, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG), will 
announce third quarter 2016 earnings on Tuesday November 1, 2016. 
 
Results press release will be      12:00 GMT / 08:00 EDT 
issued at: 
 
Investor conference call time:     14:00 GMT / 10:00 EDT 
 
Live conference call for investors: 
 
Flemming Ornskov, MD, Chief Executive Officer and Jeff Poulton, Chief Financial 
Officer will host the investor and analyst conference call at 10:00 EDT / 14:00 
GMT. 
 
The details of the conference call are as follows: 
 
UK dial in:                  0808 237 0030 or 020 3139 4830 
 
US dial in:                  1 866 928 7517 or 1 718 873 9077 
 
International Access         http://events.arkadin.com/ev/docs/ 
Numbers:                     NE_FEL_Events_International_Access_List.pdf 
 
Password/Conf ID:            42020034# 
 
Live Webcast:                http://investors.shire.com/quarterly-results/ 
 
Replay: 
 
A replay of the presentation will be available for two weeks by phone and by 
webcast for three months.  Replay information can be found on the Investor 
Relations section of Shire's website at http://investors.shire.com/. 
 
For further information please contact: 
 
Investor Relations 
 
Sarah Elton-Farr                      [e-mail] [phone] 
 
Ian Karp                              [e-mail]      [phone] 
 
Robert Coates                         [e-mail]    [phone] 
 
Notes to editors 
 
About Shire 
 
Shire is the leading global biotechnology company focused on serving people 
with rare diseases and other highly specialized conditions. We strive to 
develop best-in-class products, many of which are available in more than 100 
countries, across core therapeutic areas including Hematology, Immunology, 
Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / 
Internal Medicine / Endocrine and Hereditary Angioedema; and a growing 
franchise in Oncology. 
 
Our employees come to work every day with a shared mission: to develop and 
deliver breakthrough therapies for the hundreds of millions of people in the 
world affected by rare diseases and other high-need conditions, and who lack 
effective therapies to live their lives to the fullest. 
 
www.shire.com 
 
 
 
END 
 

(END) Dow Jones Newswires

October 19, 2016 10:00 ET (14:00 GMT)